Caas Capital Management LP Akouos, Inc. Transaction History

Caas Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.93 - $13.59 $389,752 - $533,407	-39,250 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$11.87 - $15.96 $2.27 Million - $3.06 Million	-191,534 Reduced 82.99%	39,250 $493,000
Q1 2021 May 17, 2021	SELL	$13.87 - $21.04 $2.33 Million - $3.53 Million	-167,966 Reduced 42.12%	230,784 $3.2 Million
Q4 2020 Feb 12, 2021	BUY	$17.03 - $22.45 $6.54 Million - $8.62 Million	383,750 Added 2558.33%	398,750 $7.91 Million
Q2 2020 Aug 14, 2020	BUY	$22.0 - $22.5 $330,000 - $337,500	15,000 New	15,000 $338,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.